retatrutide polaris news october 2025 Demand for Unapproved Weight-Loss Drug Surges on Social Media What is Retatrutide & When

A patient should also ask about evaluation if a clinician has previously mentioned NAFLD, MASLD, NASH, MASH, steatosis, elevated ALT, elevated AST, or liver fibrosis risk

The condition typically affects the upper lid but can also occur in the lower lid

The results showed a significant decrease in mean body weight, with a reduction of 12.1% compared to the placebo group

GLP-1 receptor agonists are licensed in the UK for type 2 diabetes mellitus and specific weight management indications, not for cognitive impairment or dementia GLP-1 receptors are present in brain regions involved in memory and learning, prompting research into potential neuroprotective effects Ongoing clinical trials, including studies of semaglutide in Alzheimer's disease, are examining whether these medications benefit cognitive function Common adverse effects include gastrointestinal symptoms

However, this enhanced fertility creates an important safety consideration, as these medications are not recommended during pregnancy